اخبار و اعلانات

 آمار

تعداد نشریات286
تعداد نشریات سازمان84
تعداد شماره‌ها2,846
تعداد مقالات32,300
تعداد مشاهده مقاله41,387,034
تعداد دریافت فایل اصل مقاله18,562,153
Abdulsada Al-Ghuraibawi, N. H, Zeki Al-Fadhel, S, Mohammed Ali, D. M, Kadhem Al-Hakeim, H. (1400). Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19. سامانه مدیریت نشریات علمی, 77(1), 449-459. doi: 10.22092/ari.2021.356682.1894
N. H Abdulsada Al-Ghuraibawi; S Zeki Al-Fadhel; D. M Mohammed Ali; H Kadhem Al-Hakeim. "Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19". سامانه مدیریت نشریات علمی, 77, 1, 1400, 449-459. doi: 10.22092/ari.2021.356682.1894
Abdulsada Al-Ghuraibawi, N. H, Zeki Al-Fadhel, S, Mohammed Ali, D. M, Kadhem Al-Hakeim, H. (1400). 'Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19', سامانه مدیریت نشریات علمی, 77(1), pp. 449-459. doi: 10.22092/ari.2021.356682.1894
Abdulsada Al-Ghuraibawi, N. H, Zeki Al-Fadhel, S, Mohammed Ali, D. M, Kadhem Al-Hakeim, H. Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19. سامانه مدیریت نشریات علمی, 1400; 77(1): 449-459. doi: 10.22092/ari.2021.356682.1894

Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19

Archives of Razi Institute
مقاله 55، دوره 77، شماره 1، فروردین و اردیبهشت 2022، صفحه 449-459    اصل مقاله (618.71 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2021.356682.1894
نویسندگان
N. H Abdulsada Al-Ghuraibawi1؛ S Zeki Al-Fadhel* 2؛ D. M Mohammed Ali3؛ H Kadhem Al-Hakeim4
1Department of Pharmacology, College of Pharmacy, University of Kufa, Kufa, Iraq
2Department of Clinical Laboratory Science, College of Pharmacy, University of Kufa, Kufa, Iraq
3Department of Biochemistry, College of Medicine, University of Kufa, Kufa, Iraq
4Department of Chemistry, College of Science, University of Kufa, Kufa, Iraq
چکیده
Cigarette smoking is a risk factor associated with different diseases, claiming millions of lives annually. Smoking status has been studied for a long time and proved to be a major cause of smokers' decreased immunity. In the present pandemic COVID-19 disease, there was an unclear belief about the effect of smoking on patients with COVID-19. Therefore, the current cross-sectional study aimed to evaluate the effect of cigarette smoking on the sequelae of COVID-19. This cross-sectional study involved 200 COVID-19 patients (114 males and 86 females) aged 13-77 years. A number of 87 patients were smokers, and the rest of them were non-smokers. All patients underwent a comprehensive laboratory assessment and diagnosis by full medical history by the physicians. The results indicated a significant difference (P<0.001) between smokers and non-smokers in terms of hypertension, anticoagulant, steroid therapy, pulmonary lesion, oxygen saturation, and duration of disease. As an overall conclusion, it can be stated that COVID-19 is less severe in smokers and they require less intensive treatment.
کلیدواژه‌ها
Cigarette smoking؛ COVID-19؛ Smokers؛ Non-smokers
سایر فایل های مرتبط با مقاله
مراجع
  1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
  2. Burlacu A, Mavrichi I, Crisan-Dabija R, Jugrin D, Buju S, Artene B, et al. “Celebrating old age”: an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly. Arch Med Sci. 2021;17(2):285.
  3. Dadras O, hahrokhnia n, Borran S, Seyedalinaghi S. Factors Associated with COVID-19 Morbidity and Mortality: A Narrative Review. J Iran Med Council. 2020.
  4. Wenzl T. Smoking and COVID-19: Did we overlook representativeness? Tob Induc Dis. 2020;18:1-2.
  5. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18:20.
  6. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 2020;15(5):845-52.
  7. Smith JC, Sheltzer JM. Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2. BioRxiv. 2020.
  8. Farsalinos K, Bagos PG, Giannouchos T, Niaura R, Barbouni A, Poulas K. Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. Harm Reduct J. 2021;18(1):9.
  9. Liu W, Tao Z-W, Wang L, Yuan M-L, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032.
  10. Patanavanich R, Glantz SA. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res. 2020;22(9):1653-6.
  11. Ahmed N, Maqsood A, Abduljabbar T, Vohra F. Tobacco Smoking a Potential Risk Factor in Transmission of COVID-19 Infection. Pak J Med Sci. 2020;36(Covid19-s4):S104-s7.
  12. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-7.
  13. WHO. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 29 March 2020. World Health Organization; 2020.
  14. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749-62.
  15. Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). Multidis Digital Publish Inst; 2020.
  16. Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, Lopez-Najera A, Jimenez-Diaz L, Navarro-Lopez JD, et al. Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm. Front Immunol. 2020;11:1359.
  17. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18.
  18. Han L, Ran J, Mak Y-W, Suen LK-P, Lee PH, Peiris JSM, et al. Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis. Epidemiology. 2019;30(3):405-17.
  19. Silva AAMd. On the possibility of interrupting the coronavirus (COVID-19) epidemic based on the best available scientific evidence. SciELO Public Health; 2020.
  20. Khot WY, Nadkar MY. The 2019 novel coronavirus outbreak-a global threat. J Assoc Physicians India. 2020;68(3):67-71.
  21. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497-506.
  22. Tonnesen P, Marott JL, Nordestgaard B, Bojesen SE, Lange P. Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study. Tob Induc Dis. 2019;17.
  23. Zhou Z, Chen P, Peng H. Are healthy smokers really healthy? Tobacco induced diseases. 2016;14(1):1-12.
  24. Prats-Uribe A, Xie J, Prieto-Alhambra D, Petersen I. Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data. Clin Epidemiol. 2021;13:357.
  25. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-8.
  26. Arcavi L. Benowitz NL. Cigarette smoking and infection Arch Intern Med. 2004;164:2206-16.
  27. Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRxiv. 2020.
  28. Alwis KU, deCastro BR, Morrow JC, Blount BC. Acrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005-2006. Environ Health Perspect. 2015;123(12):1302-8.
  29. Lawrence H, Hunter A, Murray R, Lim W, McKeever T. Cigarette smoking and the occurrence of influenza–Systematic review. J Infect. 2019;79(5):401-6.
  30. Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2018;315(5):895-906.
  31. Naik P, Cucullo L. Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products. Fluid Barriers CNS. 2015;12(1):1-15.
  32. Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F. COVID-19 and smoking: is nicotine the hidden link? Eur Respir J. 2020;55(6).
  33. Theodoros VG, Roberto AS, José MM. Retraction notice for: "Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases. Eur Respir J. 2021;57(3).
  34. Li J, Long X, Zhang Q, Fang X, Li N, Fedorova B, et al. Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging. J Intern Med. 2021;289(4):574-83.
  35. Uğur Chousein EG, Çörtük M, Cınarka H, Tanrıverdi E, Turan D, Yıldırım BZ, et al. Is there any effect of smoking status on severity and mortality of hospitalized patients with COVID-19 pneumonia? Tuberk Toraks. 2020;68(4):371-8.
  1. Archie SR, Cucullo L. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Int J Mol Sci. 2020;21(11).
  2. Cattaruzza MS, Zagà V, Gallus S, D'Argenio P, Gorini G. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature. Acta Biomed. 2020;91(2):106-12.
  3. Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, et al. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep. 2020;7:658-63.
  4. Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2018;315(5):R895-R906.
  5. Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020;31(5):454-70.
  6. Vleeming W, Rambali B, Opperhuizen A. The role of nitric oxide in cigarette smoking and nicotine addiction. Nicotine Tob Res. 2002;4(3):341-8.
  7. Regev G, Martins J, Sheridan MP, Leemhuis J, Thompson J, Miller C. Feasibility and preliminary safety of nitric oxide releasing solution as a treatment for bovine mastitis. Res Vet Sci. 2018;118:247-53.
  8. Proud D. Nitric oxide and the common cold. Current opinion in allergy and clinical immunology. Curr Opin Allergy Clin Immunol. 2005;5(1):37-42.
آمار
تعداد مشاهده مقاله: 1,317
تعداد دریافت فایل اصل مقاله: 372


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب